These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28219287)

  • 1. Overview of the Moral Status of iPS Cells.
    Martinho AM
    New Bioeth; 2016 Jul; 22(2):148-154. PubMed ID: 28219287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No ethical bypass of moral status in stem cell research.
    Brown M
    Bioethics; 2013 Jan; 27(1):12-9. PubMed ID: 21726260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ethics of stem cells revisited.
    de Miguel-Beriain I
    Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The race toward 'ethically universally acceptable' human pluripotent (embryonic-like) stem cells: only a problem of sources?
    Neri D
    Bioethics; 2011 Jun; 25(5):260-6. PubMed ID: 20002068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. We Are Human Beings.
    McGee A
    J Med Philos; 2016 Apr; 41(2):148-71. PubMed ID: 26810918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moral Limits of Brain Organoid Research.
    Koplin JJ; Savulescu J
    J Law Med Ethics; 2019 Dec; 47(4):760-767. PubMed ID: 31957593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in stem cell research on neurologic and orthopedic conditions.
    Banja JD
    PM R; 2015 Apr; 7(4 Suppl):S66-S75. PubMed ID: 25595666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blurring nature at its boundaries. Vague phenomena in current stem cell debate.
    Hähnel M
    Med Health Care Philos; 2017 Sep; 20(3):373-381. PubMed ID: 28176166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10th anniversary of iPS cells: the challenges that lie ahead.
    Aoi T
    J Biochem; 2016 Sep; 160(3):121-9. PubMed ID: 27387749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance ontology cannot determine the moral status of embryos.
    Morris J
    J Med Philos; 2012 Aug; 37(4):331-50. PubMed ID: 22892242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IPS an ethical paradigm for biomedical research].
    Gámez Escalona JA
    Cuad Bioet; 2013; 24(82):419-42. PubMed ID: 24483317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.